Chemotherapy allogeneic transplantation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy17

Allografts Hematopoietic Stem Cells T-Lymphocytes Blood Cells Bone Marrow Cells Fetal Blood Killer Cells, Natural Antilymphocyte Serum Bone Marrow Spleen Cells, Cultured Lymphocytes Transplants Dendritic Cells Liver T-Lymphocytes, Cytotoxic Cell Line, Tumor

Organisms10

Transplantation Chimera Mice, Inbred C57BL Mice, Inbred BALB C Cytomegalovirus Radiation Chimera Rats, Inbred Lew Chimera Mice, SCID Mice, Inbred C3H Mice, Inbred Strains

Diseases49

Graft vs Host Disease Hematologic Neoplasms Recurrence Multiple Myeloma Leukemia Leukemia, Myeloid, Acute Precursor Cell Lymphoblastic Leukemia-Lymphoma Acute Disease Leukemia, Myelogenous, Chronic, BCR-ABL Positive Myelodysplastic Syndromes Leukemia, Myeloid Neoplasm, Residual Lymphoma, Non-Hodgkin Lymphoma Hepatic Veno-Occlusive Disease Hodgkin Disease Cytomegalovirus Infections Breast Neoplasms Lymphoma, Follicular Chronic Disease Neoplasm Recurrence, Local Postoperative Complications Liver Failure Lung Neoplasms Neoplasms Leukemia, Lymphocytic, Chronic, B-Cell Anemia, Aplastic Hematologic Diseases Liver Neoplasms Neutropenia Cadaver Liver Diseases Infection Neoplasm Metastasis Blood Group Incompatibility Disease Progression Ovarian Neoplasms Vomiting Testicular Neoplasms Carcinoma, Non-Small-Cell Lung Lymphoproliferative Disorders Adenocarcinoma Kidney Failure, Chronic Nausea Opportunistic Infections Stomatitis Disease Models, Animal Colorectal Neoplasms Neoplasms, Second Primary

Chemicals and Drugs50

Immunosuppressive Agents Myeloablative Agonists Cyclophosphamide Antineoplastic Agents Vidarabine Busulfan Granulocyte Colony-Stimulating Factor Melphalan Antigens, CD34 Cyclosporine Cisplatin HLA Antigens Doxorubicin Methotrexate Antibodies, Neoplasm Etoposide Antibodies, Monoclonal Isoantigens Cytarabine Antigens, CD Recombinant Proteins Tacrolimus Carboplatin Antineoplastic Agents, Alkylating Paclitaxel Vinblastine Carmustine Ifosfamide Antilymphocyte Serum Benzamides Bleomycin Taxoids Antimetabolites, Antineoplastic Pyrimidines Piperazines Deoxycytidine Anthracyclines Organoplatinum Compounds Thiotepa Isoantibodies Histocompatibility Antigens Antibodies, Monoclonal, Humanized Mitoxantrone Antineoplastic Agents, Phytogenic Mycophenolic Acid Antibiotics, Antineoplastic Antibodies, Monoclonal, Murine-Derived Minor Histocompatibility Antigens Daunorubicin Dacarbazine

Analytical, Diagnostic and Therapeutic Techniques and Equipment98

Transplantation, Homologous Hematopoietic Stem Cell Transplantation Bone Marrow Transplantation Transplantation Conditioning Antineoplastic Combined Chemotherapy Protocols Transplantation, Autologous Liver Transplantation Stem Cell Transplantation Treatment Outcome Kidney Transplantation Transplantation, Isogeneic Chemotherapy, Adjuvant Peripheral Blood Stem Cell Transplantation Combined Modality Therapy Survival Analysis Heart Transplantation Survival Rate Hematopoietic Stem Cell Mobilization Lung Transplantation Disease-Free Survival Histocompatibility Testing Blood Component Removal Remission Induction Whole-Body Irradiation Cord Blood Stem Cell Transplantation Salvage Therapy Retrospective Studies Organ Transplantation Lymphocyte Depletion Immunosuppression Prognosis Islets of Langerhans Transplantation Follow-Up Studies Leukapheresis Pancreas Transplantation Transplantation Cell Transplantation Lymphocyte Transfusion Life Tables Skin Transplantation Prospective Studies Transplantation, Heterotopic Immunomagnetic Separation Risk Factors Neoadjuvant Therapy Heart-Lung Transplantation Multivariate Analysis Neoplasm Staging Drug Administration Schedule Lymphocyte Culture Test, Mixed Lymphocyte Activation Transplantation, Heterologous Fetal Tissue Transplantation Cell Separation Incidence Immunophenotyping Corneal Transplantation Induction Chemotherapy Actuarial Analysis Cell Count Polymerase Chain Reaction Kaplan-Meier Estimate Tissue Transplantation Mesenchymal Stem Cell Transplantation Fatal Outcome Donor Selection Leukocyte Transfusion Neoplasm Transplantation Flow Cytometry Clinical Trials as Topic Brain Tissue Transplantation Blood Transfusion Feasibility Studies Facial Transplantation Patient Selection Organ Preservation Chemotherapy, Cancer, Regional Perfusion Proportional Hazards Models Postoperative Period Graft Enhancement, Immunologic Immunotherapy Radiotherapy Immunohistochemistry Cohort Studies Leukocyte Count Biopsy Radiotherapy, Adjuvant Infusions, Intravenous Blood Transfusion, Autologous Pilot Projects Predictive Value of Tests Tissue and Organ Harvesting Bone Marrow Purging Disease Models, Animal Immunotherapy, Adoptive Treatment Failure Preoperative Care Risk Assessment

Psychiatry and Psychology2

Nuclear Family Siblings

Phenomena and Processes22

Graft Survival Graft vs Tumor Effect Transplantation Immunology Graft Rejection Histocompatibility Graft vs Leukemia Effect Time Factors Transplantation Tolerance Lymphocyte Activation Graft vs Host Reaction Cell Count Drug Resistance, Neoplasm Chimerism Radiation Chimera Immune Tolerance Cytotoxicity, Immunologic Cell Differentiation Dose-Response Relationship, Drug Hematopoiesis Leukocyte Count Immunocompromised Host Cell Proliferation

Disciplines and Occupations2

Cytogenetics Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena3

Nuclear Family Siblings Quality of Life

Humanities1

Quality of Life

Information Science4

Survival Rate Life Tables Incidence Fatal Outcome

Named Groups5

Tissue Donors Siblings Unrelated Donors Living Donors Blood Donors

Health Care29

Treatment Outcome Survival Analysis Survival Rate Disease-Free Survival Retrospective Studies Follow-Up Studies Life Tables Prospective Studies Risk Factors Multivariate Analysis Tissue and Organ Procurement Incidence Age Factors Actuarial Analysis Kaplan-Meier Estimate Waiting Lists Fatal Outcome Donor Selection Clinical Trials as Topic Feasibility Studies Patient Selection Proportional Hazards Models Postoperative Period Cohort Studies Pilot Projects Predictive Value of Tests Treatment Failure Preoperative Care Risk Assessment

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care

Transplantation, Homologous Hematopoietic Stem Cell Transplantation Bone Marrow Transplantation Graft vs Host Disease Transplantation Conditioning Antineoplastic Combined Chemotherapy Protocols Transplantation, Autologous Liver Transplantation Transplantation Chimera Stem Cell Transplantation Graft Survival Treatment Outcome Tissue Donors Kidney Transplantation Hematologic Neoplasms Graft vs Tumor Effect Transplantation, Isogeneic Chemotherapy, Adjuvant Peripheral Blood Stem Cell Transplantation Recurrence Combined Modality Therapy Survival Analysis Transplantation Immunology Heart Transplantation Graft Rejection Survival Rate Immunosuppressive Agents Hematopoietic Stem Cell Mobilization Lung Transplantation Disease-Free Survival Myeloablative Agonists Histocompatibility Testing Cyclophosphamide Antineoplastic Agents Multiple Myeloma Vidarabine Blood Component Removal Busulfan Granulocyte Colony-Stimulating Factor Histocompatibility Graft vs Leukemia Effect Remission Induction Whole-Body Irradiation Leukemia Leukemia, Myeloid, Acute Precursor Cell Lymphoblastic Leukemia-Lymphoma Time Factors Cord Blood Stem Cell Transplantation Salvage Therapy Acute Disease Retrospective Studies Organ Transplantation Melphalan Lymphocyte Depletion Allografts Immunosuppression Antigens, CD34 Prognosis Islets of Langerhans Transplantation Follow-Up Studies Cyclosporine Hematopoietic Stem Cells T-Lymphocytes Leukapheresis Leukemia, Myelogenous, Chronic, BCR-ABL Positive Myelodysplastic Syndromes Pancreas Transplantation Transplantation Leukemia, Myeloid Neoplasm, Residual Nuclear Family Cell Transplantation Lymphocyte Transfusion Lymphoma, Non-Hodgkin Cisplatin HLA Antigens Life Tables Doxorubicin Methotrexate Siblings Lymphoma Hepatic Veno-Occlusive Disease Hodgkin Disease Skin Transplantation Blood Cells Antibodies, Neoplasm Prospective Studies Transplantation, Heterotopic Transplantation Tolerance Immunomagnetic Separation Etoposide Bone Marrow Cells Mice, Inbred C57BL Unrelated Donors Living Donors Cytomegalovirus Infections Antibodies, Monoclonal Mice, Inbred BALB C Blood Donors Risk Factors

No FAQ available that match "chemotherapy allogeneic transplantation"